Compare Bath & Body Works Inc (BBWI) vs Goldman Sachs Group Inc (GS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs Goldman Sachs Group Inc — how do they compare? Bath & Body Works Inc trades at $19.4 (market cap $4.12B), while Goldman Sachs Group Inc trades at $1,142.6 (market cap $308.55B). The key difference: Goldman Sachs Group Inc is far larger — about 74.9× Bath & Body Works Inc's market cap, and Bath & Body Works Inc pays the higher dividend (3.92%). Which is the better fit depends on your goals.
| BBWI | GS | |
|---|---|---|
Market Cap | $4.12B | $308.55B |
Sector | Consumer Cyclical | Financials |
52-Week High | $33.11 | $1.14K |
52-Week Low | $14.85 | $700.41 |
Enterprise Value | $8.01B | — |
Dividend Yield | 3.92% | 1.72% |
Volume | — | 2,592,735 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BBWI trades at $20.42, up 0.44% today, with a bearish technical signal but attractive valuation metrics including a P/E of 5.8 and P/S of 0.58. Recent earnings show mixed quarterly beats, with Q1 2026 exceeding expectations. The company maintains solid profitability with a 10.03% net income margin and positive cash flow trends projected for 2026. Strategic initiatives include a new Ulta Beauty partnership and international expansion to drive growth amid declining revenue trends.
Outlook: BBWI presents a value opportunity with deep valuation discounts and operational strengths, though persistent revenue declines and high debt pose risks. Analyst consensus is cautiously optimistic with a $22 price target, suggesting modest upside potential if turnaround efforts gain traction against competitive and macroeconomic headwinds.
Goldman Sachs (GS) trades at $1,140, up 8.04% in the past 24 hours, with a bullish technical outlook and strong earnings momentum after beating EPS estimates for three consecutive quarters. The stock shows robust fundamentals with a 29.89% net income margin and 15.69% ROE, supported by positive analyst sentiment and involvement in high-profile IPOs like Anthropic. Revenue growth accelerated to $58.28 billion in 2025, though cash flow trends remain volatile.
The outlook for GS is positive, driven by investment banking strength and AI-driven IPO opportunities, but risks include negative operating cash flows and elevated debt levels. Analysts maintain a consensus price target of $1,080, with 40% recommending Buy. Investors should weigh the company's profit growth against liquidity concerns and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About Goldman Sachs Group Inc
The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.
Read more on GS →
